2016 International Congress

Monday, June 20, 2016

12:30pm-2:00pm

Quality of life and living with Parkinson’s in Ireland

I. Cassidy, P. Meskell, M.P. Butler, M. Richardson, C. Kennedy, S. Coote, P. Boers (Limerick, Ireland)

Quality of life/caregiver burden in movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Quality of life of Parkinson’s disease patients in a tertiary hospital in Hong Kong

H.F. Chan, Y.F. Cheung, D.K.W. Chau, T. Fung, I. Chan, W.C. Fong (Hong Kong, Hong Kong)

Quality of life/caregiver burden in movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Quantification of striatal dopamine transporters with [18F]PR04.MZ in patients with progressive supranuclear palsy and Parkinson’s disease

P. Chana-Cuevas, C. Juri, V. Kramer, R. Pruzzo, P. Riss, A. Amaral, F. Rösch, H. Amaral (Santiago, Chile)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Quantification of tremor and rigidity during deep brain stimulation surgery for Parkison’s disease

P. Poortvliet, A. Fytagoridis, T. Coyne, P. Silburn (Brisbane, Australia)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Quantitative MRI measurement of regional cerebellar involvement in patients with progressive supranuclear palsy

Y. Lee, D.K. Lee, J.M. Lee, S.J. Chung, J.J. Lee, Y.H. Sohn, P.H. Lee (Seoul, Korea)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

RBD increase non-motor symptom in Parkinson’s disease

Y. Wu, Y. Liu, X. Zhu, X. Zhang, S. Kuo, W.G. Ondo (Shanghai, People's Republic of China)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Real-world safety of deep brain stimulation in patients with ≤7.5 years between disease onset and device implant

M.C. Schiess, L. Tonder, M. Wells, T. Weaver, V. Stoker (Houston, TX, USA)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Recharge frequency is not driven by therapy power usage in patients implanted with rechargeable deep brain stimulation systems

T. Weaver, P. Konrad, L. Timmerman, G. Molnar, K. Stromberg (Minneapolis, MN, USA)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Rechargeable pacemaker technology in deep brain stimulation: A step forward, but nor for everyone

J. Runge, A. Wloch, M. Abdallad, M. Manu, J.K. Krauss (Hannover, Germany)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Recognition of parkinsonism in African Americans in a community-based sample

D.A. Hall, B. Ouyang, J.M. Shulman, L.M. Shulman, D.A. Bennett, L.L. Barnes (Chicago, IL, USA)

Epidemiology  ·  Exhibit Hall located in Hall B, Level 2